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Expression of c-myc and c-fms oncogenes in
trophoblastic cells in hydatidiform mole and
normal human placenta
A N Y Cheung, G Srivastava, S Pittaluga, T K Man, H Ngan, R J Collins
Abstract
Aims:To compare the expression ofc-inc
and c-fins proto-oncogenes in the pla-
centa and hydatidiform mole.
Methods: Twelve hydatidiform moles and
six induced abortion cases were coilected.
c-inyc and c-fins proto-oncogene expres-
sion was analysed by northern blot
hybridisation and immunohistochemical
staining.
Results: The results of northern blot
hybridisation analysis showed that c-fins
was expressed more strongly in hydatidi-
form moles compared with normal
placenta of similar gestational age.
Moreover, c-fJns mRNA concentrations
increased with more advanced gestational
age in moles but not in normal placentas.
c-nyc expression was very low in hydati-
diform moles and normal placentas. Both
oncogenes, however, had no direct corre-
lation with the clinical course ofthe molar
pregnancies.
Conclusion: The difference in c-fins
expression between hydatidiform moles
and normal placentas suggests that c-fins
may have a role in the development of
molar pregnancies.
(7 Clin Pathol 1993;46:204-207)
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The trophoblast of early placenta can pro-
liferate rapidly and infiltrate the decidua and
myometrium at the placental site.' Expression
of certain cellular proto-oncogenes may be
associated with rapid cell growth in these early
trophoblast. A strong correlation between
c-nyc transcript concentrations and tropho-
blastic proliferation has been reported.2 It has
also been suggested that colony stimulating
factor-l (CSF-1), a glycoprotein growth factor
required for the proliferation and differentia-
tion of mononuclear phagocytic cells, may
have a role in placental development and
function under hormonal influence.3 The c-fins
proto-oncogene product is related to the recep-
tor for the CSF-1,4 but in situ hybridisation
studies indicate that c-fins mRNA is associated
with trophoblast in human placenta.5
The pathogenesis of hydatidiform moles has
remained a mystery for decades. The difference
between physiological oncogene expression in
early placenta and that seen in molar pregnan-
cies is unknown. It would also be useful to
ascertain whether there is a particular pattern
of oncogene expression in moles which will
later progress into invasive moles or chor-
iocarcinoma. This study aimed to investigate
the expression of c-myc and c-fins proto-
oncogenes in hydatidiform moles compared
with that in normal placenta.
Methods
Twelve clinically and ultrasonographically sus-
pected cases of hydatidiform mole and six
legally induced abortions were suction evac-
uated. Fresh chorionic villi and molar vesicles
were selected and snap frozen in liquid nitro-
gen and stored at - 70°C.The rest of the tissue
was fixed in formalin for histological exam-
ination.
Human HL-60 promyelocytic leukaemia cell
line6 and human HUT78T cell lymphoma cell
line were maintained in logarithmic growth
phase; total RNA was extracted and used as
positive controls for c-mc and c-fins expres-
sion, respectively.
The probes used were c-myc-exonIII (1-8
kilobase insert) from Oncor (Gaithersburg,
USA) and c-fins cDNA clone pCfins 104 in
PUC12 (1-23 kilobase insert) from American
Type Culture Collection (Maryland, USA).
The cDNA probes were labelled by an oligo-
labelling procedure (Bresatec, Australia).
Total cellular RNA was extracted by the
guanidine hydrochloride procedure and unde-
graded RNA was obtained from eight moles
and six abortion cases.7 Haematoxylin and
eosin stained sections of each frozen tissue
block were examined to exclude contamination
by decidua and to ensure roughly equal num-
bers of molar villi in the tissue block. Aliquots
of total RNA (20 ,pg) from each sample were
denatured and subjected to electrophoresis on
1
-0% agarose gels containing l lM formalde-
hyde. Equivalent amounts ofRNA were loaded
into each lane as judged by ethidium bromide
staining. RNA was then transferred to nylon
membranes (Gene Screen Plus, NEN, Du
Pont, Boston, Massachusettes, USA). The
membranes were prehybridised in a solution
containing 50% formamide, 1M sodium chlo-
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Figure 1 Representative autoradiogram of northern blot hybridised with 32P-labelled
c-fins cDNA probe. Total RNA was isolatedfrom the normal placentas at five, eight,
nine, I0 and 16 weeks ofpregnancy as well as from hydatidiform moles at six, nine, 10,
12, 16 weeks'gestational age. The transcripts of c-fins was detected in the appropriate
range of 4-2 kilobases. The positions of 18S and 28S ribosomal RNA are indicated. The
results of the probing of '2P-labelled 28S ribosomal RNA is shown in the lower panel B.
Signals were quantitated by densitometric
scanning of the autoradiograms.
Frozen sections (6 pm) of the stored frozen
samples were cut, air-dried, and fixed in 4%
paraformaldehyde. The sections were stained
with mouse monoclonal antibody to c-myc
oncoprotein and rabbit polyclonal antibody to
c-fins oncoprotein (Cambridge Research Bio-
chemials, England)9 and monoclonal mouse
antibody to human Ki-67 antigen (Dako,
Copenhagen, Denmark). The alkaline-phos-
phatase anti-alkaline-phosphatase method, as
described by Cordell, was used.'0 Negative
controls were used by omitting the primary
antibody in each case. Positive controls were
obtained by cytospin of the human HL-60 and
HUT-78 cell lines as well as by including a
lymphoma case with a high proliferative rate.
ride, 10% dextran sulphate, 1% sodium
dodecyl sulphate (SDS), 0-2% polyvinylpyrro-
lidone, 0-2% ficoll, 0-2% bovine serum albu-
min, 50 mM TRIS-HCI (pH 7-5), 0-1%
sodium pyrophosphate, 01 mM EDTA, and
denatured salmon sperm DNA (200 ,ug/ml) at
42°C for overnight. The membranes were
hybridised to the denatured 32P-oligolabelled
c-nyc and c-fins DNA probes (0-5-2 ng/ml) in
the same solution for 24 hours. The final wash
of the membranes was in a solution containing
0 1 x SSC (30 mM sodium chloride, 3 mM
sodium citrate), 1% SDS, 0-1% sodium pyro-
phosphate, and 0 1 mM EDTA at 65°C for 60
minutes. The membranes were also stripped
and reprobed with 28S ribosomal RNA oligo-
meric probe to ensure that equal amounts of
RNA were loaded in each lane and that the
transfer was quantitative.8 Autoradiography
was carried out using X-OMAT AR x-ray film
(Kodak) with intensifying screens at -70°C.
Figure 2 Relative changes
in c-fins RNA expression
in (A) normal placentas
and (B) hydatidiform
moles. The arbitrary
scanner units represent
densitometric readings from
the five normal placentas
and the five hydatidiform
moles at the stated
gestational age.
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Results
Histological examination showed that all the
moles collected were complete moles. There
were no detectable differences in the accumu-
lation of macrophages in the moles and pla-
centas examined. The gestational ages of the
hydatidiform moles thus selected for analysis
ranged from six to 16 weeks while the abortion
cases ranged from five to 16 weeks. In the cases
studied two hydatidiform moles had persis-
tently raised serum concentrations of human
chorionic gonadotrophin (hCG) during follow
up and single agent chemotherapy was given.
The results of northern blot hybridisation
analysis showed that higher mRNA concentra-
tions of c-fins were found in hydatidiform
moles compared with those in normal placenta
of comparable gestational age (fig 1). More-
over, c-fins expression increased with more
advanced gestational age in moles, but in
normal placentas the c-fms concentration
reduced with increased gestational age. Den-
sitometric measurements of the relative c-fmis
RNA expression in normal placentas and
hydatidiform moles is shown in fig 2. Immuno-
histochemical staining carried out with the
anti-c-fis antibody clearly localised c-fms anti-
gen expression to the syncytiotrophoblast with
occasional positive staining in the Hofbauer
cells in the molar villi (fig 3). There was no
detectable accumulation ofmacrophages in the
sections. No correlation between c-fms expres-
sion and serum concentrations ofhCG during
follow up and subsequent chemotherapy in the
molar pregnancies studied could be demon-
strated.
Contrary to previous reports, c-myc expres-
sion was very low in the cases of moles and
normal placentas studied except in one case of
induced abortion at five weeks' gestation (fig
4). However, the total RNA extracted from the
HL60 cell line showed high concentrations of
c-myc mRNA. The Ki67 indices were less than
5% in all the placentas and molar pregnancies
studied.
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16 Using northern blot and in situ hybridisation,
Pfeifer-Ohlsson et al, have demonstrated the
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Figure 3 Immunohistochemical staining with anti-fins antibody in hydatidiform mole to localise c-fins antigen
expression in syncytiotrophoblast.
expression ofhuman c-myc proto-onco
early human villous cytotrophoblast
peak expression at five weeks after cor
and a deline by the end of the first trin
pregnancy related to differentiation of
phoblasts into syncytiotrophoblasts.'
low expression of c-myc in the norn
centas analysed in our study correspon(
advanced gestational age of the studied
five to 16 weeks. On the other hand,
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Figure 4 Representative northern blot hybridised with 32p labelled c-myc cDN.,
Total RNA was isolated from normal placentas at five, eight, nine, 10, and 16
pregnancy andfrom hydatidiform moles at six, nine, 10, 12, and 16 weeks' ges,
age. The transcript of c-myc was detected in the range of 2-4 kilobases in the pla
five weeks' gestation. The human HL-60 leukaemia cell line RNA was used as
positive control. The positions of 18S and 28S ribosomal RNA are indicated. T)
of the probing of '2P-labelled 28S ribosomal RNA is shown in the lower panel E
tgenes in expression of c-myc in the moles we studied is
with a contrary to the findings of previous studies.
iception Sarkar et al have demonstrated c-myc and c-ras
aester of proto-oncogene expression by in situ hybrid-
cytotro- isation in cytotrophoblasts of six hydatidiform
2 The moles.'2 The gestational age of the moles
nal pla- studied was not specified. Yokoyama et al have
ds to the also reported the expression of c-myc, c-fims,
cases- and c-sis proto-oncogenes in one mole at the
the low 10th week of gestation by northern blot analy-
sis and in situ hybridisation."'
While such low c-myc expression in our
study may have been related to the com-
paratively advanced gestational age of the
moles studied-six to 16 weeks-it may be
important to the pathogenesis of hydatidiform
mole: this has always been controversial.
Park'3A attributed the primary disturbance to
abnormalities in the trophoblast, resulting
indirectly in death of the fetus, but Hertig and
Edmonds proposed early death of the embryo
as the initiating process.'4 Fox also proposed
that moles were simply a form of abortion and
not neoplastic. 5 Suresh et al, from their
comparative study of silver stained nucleolar
organiser region counts on complete and
incomplete hydatidiform moles as well as on
missed abortions, supported the latter view.'6
Flow cytometric studies also suggested that the
correlation of the clinical course with pro-
liferative index was not significant while the
correlation with ploidy was positive.'7Thus the
S. low c-myc expression in the moles we studied
favours the hypothesis that most hydatidiform
A probe. moles are a form of abortion due to abnormal
weeks of conceptions, rather than a true neoplasia as
tational c-myc is usually high in actively proliferating
icenta at cells. This is further supported by the low
:e results growth fraction determined by anti-Ki67
3. antibody.
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Pregnancy induces a 1000-fold increase in
the murine uterine CSF-1 concentration,
which appeared to be regulated by chorionic
gonadotrophin,'8 and the synergistic action of
the female sex hormones, oestradiol and pro-
gesterone.' c-fins expression in murine pla-
centas rises steadily throughout gestation to
plateau on the 18th day.'8 Moreover, the
existence of the CSF-1 receptor and the c-fins
gene product in human choriocarcinoma and
teratocarcinoma cell lines has been demon-
strated in previous studies.3 19 20 Simultaneous
expression of a-subunits of hCG was also
observed in the teratocarcinoma. The c-fins
transcript has been localised to the syncytio-
trophoblast of hydatidiform moles and chor-
iocarcinoma, where hCG is produced.'3
Hence, c-fins may have a role in placental
development and may be related to hCG
metabolism. In our study the highest c-fins
expression found in the normal placentas was
at the 5th week of gestation; there was a steady
decline in its expression in placentas of more
advanced pregnancies. On the other hand, a
parallel increase in c-fins mRNA concentration
with advancing gestational age of moles was
observed. However, there is no demonstrable
relation between the hCG activity at diagnosis
and the intensity of c-fins expression in this
study. The patients with hydatidiform moles
were followed up with an estimation of hCG
activities and two of them received treatment
for persistently high hCG concentrations. Both
oncogenes did not seem to have a direct effect
on the clinical course of molar pregnancies.
This difference in the intensity of c-fins expres-
sion between normal placentas and moles
suggests that c-fins may have a role in the
development of hydatidiform moles.
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